All Pharma News
Pieris Announces Strategy to Maximize Partnered Milestone and Royalty Potential

Pieris Announces Strategy to Maximize Partnered Milestone and Royalty Potential
ACCESSWIRE
27 Mar 2024
Share Share
Pieris lays off 70% of staff after AstraZeneca axes collab

Pieris lays off 70% of staff after AstraZeneca axes collab
Max Bayer FIERCE BIOTECH
19 Jul 2023
Share Share
Pieris completes safety review of 10mg dose in asthma drug Phase IIa trial

Pieris completes safety review of 10mg dose in asthma drug Phase IIa trial
CLINICAL TRIALS ARENA
05 May 2023
Share Share
Pieris puts phase 2 cancer drug out on chopping block

Pieris puts phase 2 cancer drug out on chopping block
Gabrielle Masson FIERCEBIOTECH
05 Aug 2022
Share Share
Pieris doses first subject in Phase II gastric cancer drug trial

Pieris doses first subject in Phase II gastric cancer drug trial
CLINICALTRIALSARENA
17 Jan 2022
Share Share
Pieris Pharma Announces First Patient Dosed Phase 2 Gastric Cancer

Pieris Pharma Announces First Patient Dosed Phase 2 Gastric Cancer
TRIALSITENEWS
14 Jan 2022
Share Share
Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer

Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer
BIOSPACE
06 Oct 2021
Share Share
Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS

Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS
PRESS RELEASE
24 Aug 2021
Share Share
Pieris Pharma Announces Respiratory and Ophthalmology Collab with Genentech

Pieris Pharma Announces Respiratory and Ophthalmology Collab with Genentech
PRESS RELEASE
26 May 2021
Share Share
Pieris and Boston Enter into an Exclusive Worldwide Product License for PRS-342

Pieris and Boston Enter into an Exclusive Worldwide Product License for PRS-342
BUSINESSWIRE
26 Apr 2021
Share Share